Trials / Completed
CompletedNCT01424137
Inspiratory Flow Parameters of Easyhaler and Diskus Inhalers (SALIF)
Inspiratory Flow Parameters With Placebo Dry Powder Inhalers, Easyhaler and Diskus; an Open, Randomised, Multicentre Study in Patients With Asthma or COPD
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 227 (actual)
- Sponsor
- Orion Corporation, Orion Pharma · Industry
- Sex
- All
- Age
- 4 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to characterise inspiratory flow parameters across 2 Easyhaler® (EH) inhaler versions and Diskus® inhaler in patients with asthma (including children, adults, and the elderly) and in patients with chronic obstructive pulmonary disease (COPD).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Easyhaler type A | Easyhaler type A inhaler, 3 consecutive inhalations |
| DEVICE | Easyhaler type B | Easyhaler type B inhaler, 3 consecutive inhalations |
| DEVICE | Diskus inhaler | Diskus inhaler, 3 consecutive inhalations |
Timeline
- Start date
- 2011-09-01
- Primary completion
- 2011-11-01
- Completion
- 2011-11-01
- First posted
- 2011-08-26
- Last updated
- 2012-02-03
Locations
5 sites across 2 countries: Estonia, Finland
Source: ClinicalTrials.gov record NCT01424137. Inclusion in this directory is not an endorsement.